Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity

Bibliographic Details
Main Authors: Pawelec Graham, Rees Robert, Müller Ludmila, McArdle Stephanie, Knights Ashley
Format: Article
Language:English
Published: BMC 2004-07-01
Series:Cancer Cell International
id doaj-833ec5453c1040148320e4801cc17647
record_format Article
spelling doaj-833ec5453c1040148320e4801cc176472020-11-24T23:55:15ZengBMCCancer Cell International1475-28672004-07-014Suppl 1S5010.1186/1475-2867-4-S1-S50Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicityPawelec GrahamRees RobertMüller LudmilaMcArdle StephanieKnights Ashley
collection DOAJ
language English
format Article
sources DOAJ
author Pawelec Graham
Rees Robert
Müller Ludmila
McArdle Stephanie
Knights Ashley
spellingShingle Pawelec Graham
Rees Robert
Müller Ludmila
McArdle Stephanie
Knights Ashley
Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
Cancer Cell International
author_facet Pawelec Graham
Rees Robert
Müller Ludmila
McArdle Stephanie
Knights Ashley
author_sort Pawelec Graham
title Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
title_short Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
title_full Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
title_fullStr Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
title_full_unstemmed Identification of a novel epitope derived from the cancer-germline antigen, HAGE, displaying both in-vitro and in-vivo immunogenicity
title_sort identification of a novel epitope derived from the cancer-germline antigen, hage, displaying both in-vitro and in-vivo immunogenicity
publisher BMC
series Cancer Cell International
issn 1475-2867
publishDate 2004-07-01
work_keys_str_mv AT pawelecgraham identificationofanovelepitopederivedfromthecancergermlineantigenhagedisplayingbothinvitroandinvivoimmunogenicity
AT reesrobert identificationofanovelepitopederivedfromthecancergermlineantigenhagedisplayingbothinvitroandinvivoimmunogenicity
AT mullerludmila identificationofanovelepitopederivedfromthecancergermlineantigenhagedisplayingbothinvitroandinvivoimmunogenicity
AT mcardlestephanie identificationofanovelepitopederivedfromthecancergermlineantigenhagedisplayingbothinvitroandinvivoimmunogenicity
AT knightsashley identificationofanovelepitopederivedfromthecancergermlineantigenhagedisplayingbothinvitroandinvivoimmunogenicity
_version_ 1725463388217147392